4893 items matching your search terms.

Quality of life assessment in patients with K-RAS wild-type chemotherapy refractory metastatic colorectal cancer treated with cetuximab plus brivanib alaninate

Ringash, J Au, HJ Siu, LL Shapiro, JD Jonker, DJ Zalcberg, JR Moore, MJ Strickland, AH Kotb, R Jeffery, M Alcindor, T Ng, S Salim, M Sabesan, SS Easaw, JC Shannon, JA El-Tahche, F Walters, IB Tu, D O'Callaghan, CJ the NCIC-CTG, and the AGITG,

High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy

Savdie, R Horvath, LG Benito, RP Rasiah, KK Haynes, AM Chatfield, M Stricker, PD Turner, JJ Delprado, W Henshall, SM Sutherland, RL Kench, JG
BJU INTERNATIONAL, 2012     DOI:10.1111/j.1464-410X.2011.10572.x

Projecting the radiation oncology workforce in Australia

Schofield, D Callander, E Kimman, M Scuteri, J Fodero, L
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012     DOI:10.7314/apjcp.2012.13.4.1159

Association between co-morbidities and labour force participation amongst persons with back problems

Schofield, DJ Callander, EJ Shrestha, RN Passey, ME Percival, R Kelly, SJ
PAIN, 2012     DOI:10.1016/j.pain.2012.06.020

Letter to the editor regarding Kawada's comments on the paper labour force participation and the influence of having CVD on income poverty of older workers [letter]

Schofield, DJ Callander, EJ Shrestha, RN Percival, R Kelly, SJ Passey, ME

Labor force participation and the influence of having back problems on income poverty in Australia

Schofield, DJ Callander, EJ Shrestha, RN Percival, R Kelly, SJ Passey, ME
SPINE, 2012     DOI:10.1097/BRS.0b013e31824481ee

Labour force participation and the influence of having CVD on income poverty of older workers

Schofield, DJ Callander, EJ Shrestha, RN Percival, R Kelly, SJ Passey, ME
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012     DOI:10.1016/j.ijcard.2011.03.020

The impact of back problems on retirement wealth

Schofield, D Kelly, S Shrestha, R Callander, E Passey, M Percival, R

The long term financial impacts of CVD: living standards in retirement

Schofield, DJ Kelly, S Shrestha, R Passey, M Callander, E Percival, R

Access to general practitioner services amongst underserved Australians: a microsimulation study

Schofield, DJ Shrestha, RN Callander, EJ

The personal and national costs of early retirement because of spinal disorders: impacts on income, taxes, and government support payments

Schofield, DJ Shrestha, RN Percival, R Passey, ME Callander, EJ Kelly, SJ
SPINE JOURNAL, 2012     DOI:10.1016/j.spinee.2012.09.036

Analysis of plasma biomarkers potentially associated with antiangiogenic resistance in NCIC CTG/AGITG CO.20: a phase III randomized trial of cetuximab plus either brivanib alaninate or placebo in patients with chemotherapy refractory, k-RAS wild-type metastatic colorectal carcinoma

Shapiro, JD Siu, LL O’Callaghan, CJ Zalcberg, JR Moore, MJ Price, TJ Doyle, C Simes, J Findlay, P Cronk, MF Shaikh, A Joubert, WL Samson, B Bonaventura, A Underhill, C Wyld, D Walters, IB Phillips, P Tu, D Jonker, DJ NCIC CTG and AGITG,

Elevated D-dimer levels predict long-term thromboembolic and cardiovascular events in patients with prior myocardial infarction or unstable angina: results from the LIPID trial

Simes, RJ Blankenberg, S Hague, W Espinoza, D Sullivan, DR Zeller, T Glasziou, PP Keech, AC White, HD Tonkin, AM

Final analysis of the phase III randomized trial of cetuximab plus either brivanib alaninate or placebo in patients with metastatic chemotherapy refractory K-RAS wild-type colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 trial

Siu, LL Shapiro, JD Jonker, DJ Karapetis, CS Zalcberg, JR Simes, J Couture, F Moore, MJ Price, TJ Siddiqui, J Nott, LM Charpentier, D Liauw, WS Sawyer, MB Jefford, M Magoski, NM Haydon, AM Walters, IB Tu, D O'Callaghan, CJ NCIC Clinical Trials Group and AGITG,

Phase III randomized trial of cetuximab plus either brivanib alaninate or placebo in patients with metastatic chemotherapy refractory K-RAS wild-type colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 trial

Siu, LL Shapiro, JD Jonker, DJ Karapetis, CS Zalcberg, JR Simes, J Couture, F Moore, MJ Price, TJ Siddiqui, J Nott, LM Charpentier, D Liauw, WS Sawyer, MB Jefford, M Magoski, NM Haydon, AM Walters, IB Tu, D O'Callaghan, CJ NCIC Clinical Trials Group and AGITG,